Follow-up Cohort of Patients With Antiphospholipid Syndrome
This study is gathering updated information about Antiphospholipid Syndrome (APS) in people. APS is a condition where the body's immune system mistakenly attacks healthy tissues, which can lead to blood clots (thrombosis) or problems during pregnancy. Older studies on how often blood clots return in people with APS might not be accurate anymore because treatments have changed. Researchers are also interested in newer blood-thinning medications (called DOACs) and another drug, hydroxychloroquine, which might protect blood vessels. The main goal is to find out how often new blood clots occur at their hospital, understand what might cause them, and assess the safety of long-term treatments. This information will help plan better future studies and improve care for people with APS.
De un vistazo
¿De qué trata este estudio?
Antiphospholipid Syndrome (APS) is a condition where your body's immune system, which normally fights off infections, mistakenly attacks healthy tissues. This can sometimes lead to blood clots forming in your arteries (which carry blood away from your heart) or veins (which carry blood back to your heart). It can also cause problems during pregnancy. In some people, APS occurs on its own, and in others, it happens alongside another autoimmune condition like lupus.
Doctors usually treat APS with medicines that thin your blood to prevent clots. Over time, new blood-thinning medications have become available, and some doctors are also using a drug called hydroxychloroquine, which may help protect blood vessels. However, we need more up-to-date information on how well current treatments work and how often people with APS experience new blood clots. Older studies might not reflect the reality of today's treatments.
This study aims to get a clearer picture of APS today. It will look at people with APS over time to understand how frequently new blood clots occur. Researchers also want to identify factors that might increase the risk of these clots, see how safe long-term treatments are, and get a better understanding of how APS affects people's overall health and lifespan. This information is really important because it will help doctors and researchers design better studies in the future and ultimately improve care for people living with APS.
Puntos clave
- The study helps update our understanding of Antiphospholipid Syndrome (APS).
- It looks at how often blood clots return in people with APS.
- It also checks the safety of long-term treatments for APS.
- Your medical information will help future studies and improve care.
- You continue your usual care; no new treatments are involved.
¿Quién puede ser elegible?
To be part of this study, you need to be an adult between the ages of 18 and 75.
Crucially, you must have been diagnosed with Antiphospholipid Syndrome (APS) according to specific medical guidelines called the '2006 Sydney classification.' Your doctor will know if your diagnosis meets these requirements.
You would not be able to join the study if you are younger than 18 or older than 75, or if your APS diagnosis doesn't fit the 2006 Sydney classification guidelines.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes entre 18 y 75 años?
- Have you been diagnosed with Antiphospholipid Syndrome?
- Does your APS diagnosis meet the '2006 Sydney classification' guidelines?
- ¿Está de acuerdo en que su información médica se utilice para investigación?
¿En qué consiste la participación?
This study involves looking at your medical records from the past (retrospective) and collecting new information from you going forward (prospective). This means your doctors will monitor your health as part of your regular care, particularly watching for any new blood clots.
You will continue to receive your usual medical care and regular check-ups as recommended by your doctor for your APS. The study will mainly involve doctors collecting information from your routine visits and medical history. Your participation is about allowing researchers to gather and analyse this information to learn more about APS. The total duration of your participation will depend on how long new information is collected as part of the study.
Riesgos y beneficios potenciales
Ubicaciones (1)
- University hospital of RouenCódigo postal verificadoRouen, Francia· Reclutamiento
Preguntas comunes
What is Antiphospholipid Syndrome (APS)?
APS is a condition where your immune system mistakenly attacks certain proteins, which can make your blood more likely to clot.
¿Por qué es importante este estudio?
This study is important because it will update our knowledge about APS, especially with newer treatments available. This helps doctors give you the best advice.
Will I have to take any new medicines?
No, this study doesn't ask you to take any new medicines. It's about observing your current treatment and health.
Will my regular doctor still look after me?
Yes, your regular doctors will continue to provide all your medical care for APS.
¿Cuánto tiempo estaré involucrado en el estudio?
The study collects information over time, so your involvement will be ongoing as researchers monitor the condition and treatments. There isn't a fixed end date for individual participants' data collection.
Cómo obtener más información
Sébastien SM MIRANDA, Doctor
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.